Nitric Oxide: Exploring the Contextual Link with Alzheimer's Disease

Area of Science:

• Neuroscience
• Immunology
• Biochemistry

Background:

• Neuronal inflammation is a defense mechanism involving glial cells (microglia, astrocytes, macrophages).
• Glial cells release bioactive molecules, including nitric oxide (NO), a key regulator of physiological systems.
• NO modulates immune and neural functions, influencing inflammation and cellular processes.

Purpose of the Study:

• To explore recent data on molecular mechanisms of NO in neuronal inflammation and neurodegeneration.
• To detail NO's role in oxidative stress-associated neurodegeneration in the CNS.
• To provide updated knowledge on therapeutic strategies targeting NO in neurodegenerative diseases.

Main Methods:

• Review of experimental data and recent literature.
• Analysis of molecular pathways involving NO, cyclic GMP (cGMP), reactive oxygen species (ROS), and reactive nitrogen species (RNS).
• Investigation of NO's impact on cellular organelles like mitochondria.

Main Results:

• NO is implicated in regulating proinflammatory molecules and ROS, leading to RNS formation.
• NO targets mitochondria, contributing to cellular death, a characteristic of neurodegenerative diseases.
• Accumulating evidence highlights NO's significant role in neuroinflammation and Alzheimer's disease (AD) progression.

Conclusions:

• NO is a critical mediator in neuroinflammation and neurodegeneration, particularly in AD.
• Understanding NO's molecular actions is crucial for developing targeted therapies.
• Future research should focus on NO-modulating strategies for CNS disorders.